A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer
Clinical trial NCT02384239 · COMPLETED
Trial details
- NCT number
- NCT02384239
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-19
- Primary completion
- 2021-01-31
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.